Lipopolysaccharide down-regulates the leukotriene C4 synthase gene in the monocyte-like cell line, THP-1

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2121-2128

  Serio, Kenneth J ^a   Johns, Scott C ^a   Luo, Linda ^a   Hodulik, Craig R ^a   Bigby, Timothy D ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CALCIUM IONOPHORE; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE C4 SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PEPTIDOLEUKOTRIENE; PROTEIN INHIBITOR; PROTEIN P50; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN; CELL STRAIN THP 1; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; MONOCYTE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0037442016     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2121     Document Type: Article

References (70)

1. Figueroa, D. J., R. M. Breyer, S. K. Defoe, S. Kargman, B. L. Daugherty, K. Waldburger, Q. Liu, M. Clements, Z. Zeng, G. P. O'Neill, et al. 2001. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163:226.
2. Heise, C. E., B. F. O'Dowd, D. J. Figueroa, N. Sawyer, T. Nguyen, D. S. Im, R. Stocco, J. N. Bellefeuille, M. Abramovitz, R. Cheng, et al. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275:30531.
3. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645.
4. Namovic, M. T., R. E. Walsh, C. Goodfellow, R. R. Harris, G. W. Carter, and R. L. Bell. 1996. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats. Eur. J. Pharmacol 315:81.
5. Israel, E., R. Dermakarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323:1740.
6. 4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am. Rev. Respir. Dis. 147:1413.
7. Morlion, B. J., E. Torwestern, K. Kuhn, C. Puchstein, and P. Furst. 2000. Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill. Crit. Care Med. 28:3655.
8. Jakobsson, P.-J., R. Morgenstern, J. A. Mancini, A. W. Ford-Hutchinson, and B. Persson. 1999. Common structural features of MAPEG-a widespread super-family of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci. 8:689.
9. Jakobsson, P.-J., J. A. Mancini, D. Riendeau, and A. W. Ford-Hutchinson. 1997. Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. J. Biol. Chem. 272:22934.
10. 4 synthase. J. Biol. Chem. 276:22608.
11. 4 synthase gene expression in the monocyte-like cell line, THP-1. Am. J. Respir. Cell. Mol. Biol. 23:234.
12. 4 synthase involves a Kruppel-like transcription factor and Sp1. J. Biol. Chem. 275:8903.
13. Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:19.
14. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 60:8.
15. Strieter, R. M., S. W. Chensue, T. J. Standiford, M. A. Basha, H. J. Showell, and S. L. Kunkel. 1990. Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. Biochem. Biophys. Acta 166:886.
16. Aderem, A. A., D. S. Cohen, S. D. Wright, and Z. A. Cohn. 1986. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 164.
17. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
18. Lefer, A. M. 1989. Significance of lipid mediators in shock states. Circ. Shock 27:3.
19. Quinn, J. V., and G. J. Slotman. 1999. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Crit. Care Med. 27:2485.
20. 4 and prostaglandin 12 in patients with sepsis. Res. Commun. Mol. Pathol. Pharmacol. 86:37.
21. 4, and platelet-activating factor levels in patients with septic shock. Res. Commun. Mol. Pathol. Pharmacol. 92:131.
22. Takakuwa, T., S. Endo, H. Nakae, T. Suzuki, K. Inada, M. Yoshida, M. Ogawa, and K. Uchida. 1994. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84:271.
23. Can, C., M. G. Cinar, S. Ulker, A. Evinc, and S. Kosay. 1998. Effects of MK-886, a leukotriene biosynthesis inhibitor, in a rabbit model of endotoxic shock. Eur. J. Pharmacol. 350:223.
24. Etemadi, A. R., G. E. Tempel, B. A. Farah, W. C. Wise, P. V. Halushka, and J. A. Cook. 1987. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations. Circ. Shock 22:55.
25. Cook, J. A., E. J. Li, K. M. Spicer, W. C. Wise, and P. V. Halushka. 1990. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock. Circ. Shock 32:209.
26. Ring, W. L., C. A. Riddick, J. R. Baker, C. K. Glass, and T. D. Bigby. 1997. Activated lymphocytes increase expression of 5-lipoxygenase and its activating protein in THP-1 cells. Am. J. Physiol. 273:C2057.
27. Riddick, C. A., W. L. Ring, J. R. Baker, C. R. Hodulik, and T. D. Bigby. 1997. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246:112.
28. 4 synthase expression in the monocyte-like cell line, THP-1. J. Immunol. 162:1102.
29. Ausbel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1992. Current protocols in molecular biology. Greene and Wiley, Brooklyn, NY.
30. McLaughlin, P. J., N. J. Elwood, S. M. Russell, S. M. Andrew, and I. F. McKenzie. 1992. Properties of monoclonal antibodies to human tumor necrosis factor α (TNF α). Anticancer Res. 12:1243.
31. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999, MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777.
32. Aybay, C., and T. Imir. 1998. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A and monophosphoryl lipid A on nitric oxide, TNF-α, and IL-6 induction from RAW 264.7 macrophages. FEMS Immunol. Med. Microbiol. 22:263.
33. 4 synthase gene and assignment to chromosome 5q35. Mol. Med. 2:637.
34. Duckett, C. S., N. D. Perkins, T. F. Kowalik, R. M. Schmid, E. S. Huang, A. S. Baldwin Jr., and G. J. Nabel. 1993. Dimerization of NF-κB2 with RelA (p65) regulates DNA binding, transcriptional activation, and inhibition by an IκB-α (MAD-3). Mol. Cell. Biol. 13:1315.
35. Gorman, C., R. Padmanabhan, and B. H. Howard. 1983. High efficiency DNA-mediated transformation of primate cells. Science 221:551.
36. Viriyakosol, S., P. S. Tobias, R. L. Kitchens, and T. N. Kirkland. 2001. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276:38044.
37. Kirkland, T. N., G. D. Virca, T. Kuus-Reichel, F. K. Multer, S. Y. Kim, R. J. Ulevitch, and P. S. Tobias. 1990. Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J. Biol. Chem. 265: 9520.
38. 4 co-stimulates 5-lipoxygenase activity in neutrophils via increased 5-lipoxygenase translocation. Am. J. Physiol. 272:C1329.
39. Coffey, M. J., S. M. Phare, and M. Peters-Golden. 2000. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J. Immunol. 165:3592.
40. Opal, S. M., P. J. Scannon, J. L. Vincent, M. White, S. F. Carroll, J. E. Palardy, N. A. Parejo, J. P. Pribble, and J. H. Lemke. 1999. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180:1584.
41. 4. J. Clin. Invest. 83:970.
42. 4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS. Circ. Shock 33:7.
43. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157:5221.
44. Pfau, J. C., E. B. Walker, and G. L. Card. 1998. A comparison of the effects of lipopolysaccharide and ceramide on arachidonic acid metabolism in THP-1 monocytic cells. Cell. Immunol. 186:147.
45. 2. Cell. Signal. 14:199.
46. Wohlford-Lenane, C. L., D. C. Deetz, and D. A. Schwartz. 1999. Cytokine gene expression after inhalation of corn dust. Am. J. Physiol. 276:L736.
47. Bergamini, A., E. Faggioli, F. Bolacchi, S. Gessani, L. Cappannoli, I. Uccella, F. Demin, M. Capozzi, R. Cicconi, R. Placido, et al. 1999. Enhanced production of tumor necrosis factor-α and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J. Infect. Dis. 179:832.
48. Lafleur, R. L., M. S. Abrahamsen, and S. K. Maheswaran. 1998. The biphasic mRNA expression pattern of bovine interleukin-8 in Pasteurella haemolytica lipopolysaccharide-stimulated alveolar macrophages is primarily due to tumor necrosis factor α. Infect. Immun. 66:4087.
49. Rigato, O., S. Ujvari, A. Castelo, and R. Salomao. 1996. Tumor necrosis factor α (TNF-α) and sepsis: evidence for a role in host defense, Infection 24:314.
50. Zwaveling, J. H., J. K. Maring, F. L. Clarke, R. J. van Ginkel, P. C. Limburg, H. J. Hoekstra, H. S. Koops, and A. R. Girbes. 1996. High plasma tumor necrosis factor (TNF)-α concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-α, interferon-γ, and melphalan. Crit. Care Med. 24:765.
51. Gatanaga, T., C. D. Hwang, M. Gatanaga, F. Cappuccini, R. S. Yamamoto, and G. A. Granger. 1991. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol. 138:1.
52. Zhang, F. X., C. J. Kirschning, R. Mancinelli, X. P. Xu, Y. Jin, E. Faure, A. Mantovani, M. Rothe, M. Muzio, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611.
53. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310.
54. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
55. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.
56. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811.
57. Liu, M. K., P. Herrera-Velit, R. W. Brownsey, and N. E. Reiner. 1994. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:2642.
58. Hambleton, J., S. L. Weinstein, L. Lem, and A. L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93:2774.
59. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen activated kinase pathway regulates the human IL-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276:13664.
60. 4 biosynthesis. J. Biol. Chem. 275:10968.
61. Pahl, H. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853.
62. Böhrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jilmer, D. Männel, B. W. Böttiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFκB in the mortality of sepsis. J. Clin. Invest. 100:972.
63. Kirschning, C. J., H. Wesche, T. M. Ayres, and M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.
64. Groupp, E. R., and M. Donovan-Peluso. 1996. Lipopolysaccharide induction of THP-1 cells activates binding of c-Jun, Ets, Egr-1 to the tissue factor promoter. J. Biol. Chem. 271:12423.
65. Sohur, U. S., M. N. Dixit, C. L. Chen, M. W. Byrom, and L. A. Kerr. 1999. Rel/NF-κB represses bcl-2 transcription in pro-B lymphocytes. Gene Expression 8:219.
66. Inoue, J., L. D. Kerr, L. J. Ransone, E. Bengal, T. Hunter, and I. M. Verma. 1991. c-rel activates but v-rel suppresses transcription from κB sites. Proc. Natl. Acad. Sci. USA 88:3715.
67. Himes, S. R., L. S. Coles, R. Katsikeros, R. K. Lang, and M. F. Shannon. 1993. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene 8:3189.
68. Mackman, N., K. Brand, and T. S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J. Exp. Med. 174:1517.
69. Cogswell, P. C., M. W. Mayo, and A. S. Baldwin Jr. 1997. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-α-induced NF-κB1 transcription. J. Exp. Med. 185:491.
70. Adib-Conquy, M., C. Adrie, P. Moine, K. Asehnoune, C. Fitting, M. R. Pinsky, J. F. Dhainaut, and J. M. Cavaillon. 2000. NF-κB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am. J. Respir. Crit. Care Med. 162:1877.